Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Share-based Compensation (2021 - 2026)

Biomea Fusion (BMEA) posted Share-based Compensation of $1.6 million for Q1 2026, up 82.89% sequentially from $865000.0 in Q3 2025.

Biomea Fusion (BMEA) Share-based Compensation (2021 - 2026) Analysis & Trends

Biomea Fusion has reported Share-based Compensation for 6 years, with the latest figure at $1.6 million in Q1 2026.

  • Quarterly Share-based Compensation changed N/A year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (down 73.25% YoY) and the FY2025 annual result came in at $10.8 million, down 64.47% from the prior year.
  • Share-based Compensation grew to $1.6 million in Q1 2026 per BMEA's latest filing, from $865000.0 in the prior quarter.
  • Over five years, Share-based Compensation peaked at $15.4 million in Q2 2025 and troughed at $865000.0 in Q3 2025.
  • A 5-year average of $3.3 million and a median of $2.3 million in 2022 frame the typical range for Share-based Compensation.
  • The widest YoY moves for Share-based Compensation: up 543.81% in 2025, down 61.79% in 2025.
  • Over 5 years, Share-based Compensation stood at $2.7 million in 2022, then dropped by 8.25% to $2.5 million in 2023, then soared by 80.18% to $4.5 million in 2024, then tumbled by 80.73% to $865000.0 in 2025, then surged by 82.89% to $1.6 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $1.6 million, $865000.0, and $15.4 million for Q1 2026, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 120.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 137.41 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 86.63 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 28.05 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 41.25 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Biomea Fusion 97.69 Mn 97.69 Mn - 13.20 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 13.20 Mn
Jun 30, 2026 13.20 Mn
Mar 31, 2026 1.58 Mn
Mar 31, 2026 1.58 Mn
Sep 30, 2025 865,000.00
Sep 30, 2025 865,000.00
Jun 30, 2025 15.40 Mn
Jun 30, 2025 15.40 Mn
Dec 31, 2024 4.49 Mn
Dec 31, 2024 4.49 Mn
Sep 30, 2024 2.26 Mn
Sep 30, 2024 2.26 Mn
Jun 30, 2024 2.39 Mn
Jun 30, 2024 2.39 Mn
Mar 31, 2024 5.02 Mn
Mar 31, 2024 5.02 Mn
Dec 31, 2023 2.49 Mn
Dec 31, 2023 2.49 Mn
Sep 30, 2023 1.78 Mn
Sep 30, 2023 1.78 Mn